IRIS
SOLIMANDO, ANTONIO GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.329
AS - Asia 4.507
EU - Europa 4.366
SA - Sud America 1.186
Continente sconosciuto - Info sul continente non disponibili 970
AF - Africa 272
OC - Oceania 10
Totale 21.640
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.890
IT - Italia 1.914
SG - Singapore 1.866
BR - Brasile 919
CN - Cina 831
HK - Hong Kong 510
RU - Federazione Russa 454
SE - Svezia 417
DE - Germania 413
VN - Vietnam 364
FR - Francia 350
GB - Regno Unito 244
BD - Bangladesh 219
CA - Canada 197
IN - India 165
FI - Finlandia 153
ID - Indonesia 97
AR - Argentina 73
CI - Costa d'Avorio 67
MX - Messico 64
ZA - Sudafrica 60
NL - Olanda 58
TR - Turchia 58
CO - Colombia 57
IQ - Iraq 57
PL - Polonia 56
JP - Giappone 52
ES - Italia 51
PK - Pakistan 39
BE - Belgio 38
CZ - Repubblica Ceca 38
VE - Venezuela 34
LT - Lituania 33
AT - Austria 32
PH - Filippine 31
EC - Ecuador 30
UA - Ucraina 29
EG - Egitto 26
MA - Marocco 26
SA - Arabia Saudita 26
CR - Costa Rica 24
GT - Guatemala 24
KR - Corea 24
MY - Malesia 24
UZ - Uzbekistan 23
JO - Giordania 22
TN - Tunisia 22
CL - Cile 20
JM - Giamaica 20
NI - Nicaragua 19
AE - Emirati Arabi Uniti 17
IE - Irlanda 17
KE - Kenya 17
PY - Paraguay 17
TT - Trinidad e Tobago 17
SV - El Salvador 15
ET - Etiopia 14
HN - Honduras 14
NP - Nepal 11
PE - Perù 11
PR - Porto Rico 11
AU - Australia 10
DZ - Algeria 10
BO - Bolivia 9
IL - Israele 9
IR - Iran 9
UY - Uruguay 9
CH - Svizzera 8
GP - Guadalupe 8
EE - Estonia 7
PA - Panama 7
DK - Danimarca 6
KW - Kuwait 6
LB - Libano 6
AO - Angola 5
BB - Barbados 5
HU - Ungheria 5
OM - Oman 5
PS - Palestinian Territory 5
PT - Portogallo 5
RO - Romania 5
SR - Suriname 5
AZ - Azerbaigian 4
CW - ???statistics.table.value.countryCode.CW??? 4
HR - Croazia 4
NO - Norvegia 4
RS - Serbia 4
SC - Seychelles 4
SY - Repubblica araba siriana 4
AL - Albania 3
BG - Bulgaria 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
GD - Grenada 3
LA - Repubblica Popolare Democratica del Laos 3
QA - Qatar 3
SN - Senegal 3
TH - Thailandia 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
Totale 20.625
Salva come PNG Salva come JPEG
Città #
Ashburn 1.518
Singapore 1.100
San Jose 882
Chandler 606
Fairfield 570
Hong Kong 502
Milan 488
Council Bluffs 357
Nyköping 341
Woodbridge 306
New York 280
Beijing 277
Houston 265
Seattle 257
Cambridge 235
Los Angeles 232
Bari 212
Ann Arbor 201
Rome 200
Wilmington 177
Dallas 161
Lauterbourg 147
Santa Clara 138
Munich 114
Ho Chi Minh City 113
Helsinki 109
Dearborn 100
São Paulo 97
Boardman 93
Roxbury 93
Lawrence 92
Columbus 90
Falkenstein 84
Marseille 84
Chicago 75
Brooklyn 73
Buffalo 73
Des Moines 71
Phoenix 69
Abidjan 67
Hanoi 67
Jakarta 67
Frankfurt am Main 62
Moscow 61
Montreal 52
Orem 51
San Diego 49
London 47
Tokyo 47
Figino 46
Nanjing 44
Toronto 43
Atlanta 41
Denver 40
Inglewood 40
Johannesburg 40
Dong Ket 39
Brussels 38
Turku 36
Turin 35
Naples 33
Paris 32
Warsaw 32
Stockholm 31
Jacksonville 30
The Dalles 30
Washington 30
Chennai 27
North Bergen 27
Brno 26
Nuremberg 25
Manchester 24
Poplar 24
Redwood City 23
San Francisco 23
Baghdad 22
Mexico City 22
Rio de Janeiro 22
Boston 21
Tashkent 21
Amman 20
Guangzhou 19
Guatemala City 19
Princeton 19
Campinas 18
Elk Grove Village 18
Florence 18
Shanghai 18
Bologna 17
Haiphong 17
Managua 17
Salt Lake City 17
San José 17
Tampa 17
Curitiba 16
Dublin 16
Leawood 16
Medellín 16
Mumbai 16
Brescia 15
Totale 12.765
Salva come PNG Salva come JPEG
Nome #
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 317
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression 263
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 235
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 232
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 227
B-Cell Therapies in Relapsing Remitting and Primary Progressive Multiple Sclerosis: A Short Clinical Review 217
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer 203
The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein 200
Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma 199
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 197
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 196
Efficacy and safety of benralizumab in eosinophilic granulomatosis with polyangiitis: A meta‐analysis of eight studies 194
Microenvironment drug resistance in multiple myeloma: Emerging new players 194
HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma 194
Bortezomib treatment modulates autophagy in multiple myeloma 193
JAM-A as a Prognostic Factor and New Therapeutic Target in Multiple Myeloma 193
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study 192
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 190
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study 184
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 184
Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review 183
Targeting B-cell non Hodgkin lymphoma: New and old tricks 179
A multiple myeloma that progressed as type i cryoglobulinemia with skin ulcers and foot necrosis: A case report 176
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer 174
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 174
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 173
BL1391: an established cell line from a human malignant peripheral nerve sheath tumor with unique genomic features 170
Amyloid heart involvement lead a fast fatal evolution a healthy woman: a case report 170
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma 167
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 165
A comprehensive biological and clinical perspective can drive a patient-tailored approach to multiple myeloma: Bridging the gaps between the plasma cell and the neoplastic niche 165
Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment 164
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass 163
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target 163
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 162
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 154
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs 153
Dyspnea, Fatigue, and Generalized Weakness in a 67-Year-Old Man: Approach to the Patient Between Guidelines and Clinical Judgment 152
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection 152
Antibiotic treatment in vasculitic leg ulcers: a single center experience 149
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 149
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 149
Imaging evaluation of pulmonary and non-ischaemic cardiovascular manifestations of covid-19 149
Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine 148
A Challenging Case of Visceral Leishmaniasis 146
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery 145
Emerging Concepts in Acute Heart Failure: From the Pathophysiology to the Clinical Case Based Approach 145
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib 144
Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review 144
CIC-Mutation As a Potential Molecular Mechanism of Acquired Resistance to Combined BRAF/MEK Inhibition in CNS Multiple Myeloma 143
Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm 143
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 142
Angiogenesis and Antiangiogenesis in Multiple Myeloma 142
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF‐MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement 141
Actors on the scene: Immune cells in the myeloma niche 140
A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions 139
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs 139
Rituximab induces a reduction of lymphocyte CD3+ activated in patients with autoimmune diseases 138
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? 138
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 136
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 135
RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS 135
Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion 133
Real-life experience with omalizumab in chronic spontaneous urticaria. 133
Genomic profiling at a single center cracks the code in inborn errors of immunity 132
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 131
Rituximab use in autoimmune diseases: a single center experience. 130
Two-year follow-up after drug desensitization in mucopolysaccharidosis 129
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 127
Sonography of superficial lymph nodes in malignant lymphomas. Data from our case series. 127
Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research 127
Proangiogenic effect of bone marrow fibroblasts in patients with multiple myeloma 126
Fever, cough and breathlessness in a patient with digeorge syndrome 125
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study 124
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 122
Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting 120
The bone marrow niche landscape: a journey through aging, extrinsic and intrinsic stressors in the haemopoietic milieu 119
LIPIDS INCREASE IN HYPERTENSIVES DURING THE FIRST YEAR STEROID TREATMENT FOR GRANULOMATOSIS WITH POLYANGIITIS (GPA) 118
A Markov model for estimating the cost-effectiveness of immunotherapy for newly diagnosed multiple myeloma patients 117
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes 115
Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow 115
Telemedicine DSS-AI Multi Level Platform for Monoclonal Gammopathy Assistance 114
Prognostic role of neoplastic markers in Takotsubo syndrome 113
Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma 110
IMPACT OF REMOTE MONITORING ON PATIENTS’ QUALITY OF LIFE. A SINGLE CENTRE STUDY 109
Angiogenesis as Therapeutic Target in Metastatic Prostate Cancer – Narrowing the Gap Between Bench and Bedside 109
CARDIOVASCULAR RISK SCORE MAY BE USEFUL IN STRATIFY DEATH RISK IN HOSPITALIZED COVID19 PATIENTS 108
Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review 107
Comprehensive analysis of clinical outcomes, infectious complications and microbiological data in newly diagnosed multiple myeloma patients: a retrospective observational study of 92 subjects 107
STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure 107
Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma: Could Surgery Represent a Therapeutic Option? 106
Changes in Angiogenesis and Bone Turnover Markers in Patients with Gaucher Disease Developing Osteonecrosis 106
COVID-19 and the Endocrine System: A Comprehensive Review on the Theme 105
An atypical presentation of intestinal neuroendocrine tumor. 105
Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy 105
Electrocardiographic Pathological Findings Caused by the SARS-CoV-2 Virus Infection: Evidence from a Retrospective Multicenter International Cohort Longitudinal Pilot Study of 548 Subjects 104
Aggressive systemic mastocytosis with the co-occurrence of PRKG2::PDGFRB, KAT6A::NCOA2, and RXRA::NOTCH1 fusion transcripts and a heterozygous RUNX1 frameshift mutation 104
New insights in Diffuse Large B Cell Lymphoma Pathobiology 103
Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions 103
MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance 103
Totale 15.040
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.255
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022796 0 0 0 33 40 84 38 50 76 82 135 258
2022/20231.550 155 220 128 123 145 170 43 186 280 26 50 24
2023/2024866 48 121 54 76 75 258 32 21 20 24 16 121
2024/20253.613 150 57 172 130 134 313 538 355 160 220 522 862
2025/20268.795 1.066 374 498 903 1.019 483 904 312 1.033 813 448 942
2026/20272.746 399 547 605 1.195 0 0 0 0 0 0 0 0
Totale 21.640